ERBB2 and breast carcinoma: In a mouse model of MBC, HER2 overexpression promoted outgrowth of breast tumor-derived brain metastases, with the number of large brain metastases increasing 3-fold in mice inoculated with high HER2-expressing versus low HER2-expressing human breast cancer cells [10].